RSM logo
International Journal of STD & AIDS

Home Current issue Browse archive Alerts About the journal Feedback
 
Int J STD AIDS 2006;17:67-69
doi:10.1258/095646206775220612
© 2006 Royal Society of Medicine Press

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clark, S J
Right arrow Articles by Cramp, M E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Case reports

Reactivation of latent hepatitis B virus infection with HIV-related immunosuppression

S J Clark, S Creighton, M Horner, H M Smith, B Portmann, C Taylor and M E Cramp

Department of Liver Studies, King's College Hospital, Denmark Hill, London, UK; Department of Genito-urinary Medicine, King's College Hospital, Denmark Hill, London, UK; Department of Liver Studies, King's College Hospital, Denmark Hill, London, UK; Department of Liver Studies, King's College Hospital, Denmark Hill, London, UK; Department of Genito-urinary Medicine, King's College Hospital, Denmark Hill, London, UK; Department of Liver Studies, King's College Hospital, Denmark Hill, London, UK; Department of Liver Studies, King's College Hospital, Denmark Hill, London, UK

The effect of HIV-related immunosuppression and antiretroviral therapy on the reactivation of latent hepatitis B virus (HBV) infection is unclear. We report four patients with advanced HIV-related immunosuppression and abnormal liver function tests who had evidence of HBV reactivation. Reclearance of hepatitis B occurred in two cases with HIV treatment regimens not containing lamivudine, suggesting that improved immune function may be responsible. In three cases, HBV reactivation was recognized during investigation for abnormal liver function initially attributed to drug toxicity. The possibility of HBV reactivation must be considered in the differential diagnosis of abnormal liver function in cases with advanced HIV.

Key Words: HEPATITIS B • HIV • ANTIRETROVIRALS • IMMUNE RECONSTITUTION


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




History of the London Clinic